Israel Cidon, former dean of the Andrew and Erna Viterbi Faculty of Electrical and Computer Engineering at Technion-Israel Institute of Technology, has joined Cornell Tech as director of the Joan and Irwin Jacobs Technion-Cornell Institute.
Researchers at Weill Cornell Medicine have found that radiation therapy combined with two types of immunotherapy can control tumors in preclinical models of triple-negative breast cancer, which is typically resistant to immunotherapy alone.
Weill Cornell Medicine has received a three-year, nearly $6 million grant from the Eunice Kennedy Shriver National Institute of Child Health and Human Development to lead one of three national contraceptive research centers.
Craniosynostosis, the premature fusion of the top of the skull in infants, is caused by an abnormal excess of a previously unknown type of bone-forming stem cell, according to a preclinical study led by researchers at Weill Cornell Medicine.
Weill Cornell Medicine has been awarded a five-year, $5 million grant from the U.S. Department of Health and Human Services to study whether a bilingual video game can increase the use of contraception among Black and Hispanic adolescents.
The bones that form the spine are derived from a distinct type of stem cell that secretes a protein favoring tumor metastases, according to researchers at Weill Cornell Medicine, a discovery that opens up a new line of research on spinal disorders.
Cornell University’s Life Sciences Technology Innovation Fellowship, formerly known as the BioEntrepreneurship Initiative, enters its second year in 2023-24 with a new cohort of 15 business students and 12 researchers.
A member of an important class of ion channel proteins can transiently rearrange itself into a larger structure with dramatically altered properties, according to a study led by researchers at Weill Cornell Medicine.
